6-Substituted 1,3-dimethyl-7-hydroxylumazines (5-7) have been synthesized from 1,3-dimethyluracil-5,6-diamine (1) and a-ketoacid esters (2-4) under weakly acidic conditions. The isomeric 7-substituted 1,3-dimethyllumazin-6-ones (18-20) resulted from a regioselective Boon synthesis starting from 6-chloro-l,3-dimethyl-5-nitrouracil (8) and α-aminoacid esters (9-11) in a three-step procedure. H 2 0 2 oxidations led with 6 and 7 to the corresponding 5-N-oxides (21, 22) whereas in the lumazin-6-onc scries only the 7-phenyl derivative (20) reacted also at N-5 position forming a cyclic hydroxamic acid (23). The newly synthesized compounds have been characterized by elemental analyses, Ή-NMR and UV spectra based upon pK a -determinations.
Introduction
Naturally occurring pteridines (2-4) arc cither derivatives of the pterin or the lumazine skeleton. Since the pterin derivatives are more widely distributed in nature and show interesting biological activities their chemistry has been investigated on a broad basis. The lumazines on the other hand play a less important role and have therefore not attracted much attention from a purely chemical point of view. In this paper we relate our investigations to earlier experiments which have been dealing with the synthesis and properties of 5,6-dihydro-6-oxo-(5) and 7-hydroxylumazines (6), respectively.
Synthesis
The synthesis of 6-substituted 1,3-dimethyl-7-hydroxylumazines (5-7) can easily been performed by the condensation of l,3-methyluracil-5,6-diamine (1) with ethyl isopropyl-(2), ethyl tcrt.butyl-(3) and ethyl phenylglyoxylate (4) in H 2 0 under neutral or weakly acidic conditions to give good yields of the anticipated substances 5-7. The isomeric 7-substituted 1.3-dimethyl-5//-lumazin-6-ones (18-20) have been derived in a regioselective approach by the principie of Boon (7) starting from 6-chloro-l,3-dimethyl-5-nitrouracil (8) and the appropriate 1-substituted α-amino acid esters 9-11. The first step leads in a nucleophilic displacement reaction to 2-( 1,3-dimethyl-5-nitrouracil-6-ylamino)-acetic ethyl ester (12). 3-methylbutyric ethyl ester-(13) and phenylacctic ethyl ester (14) which cyclize rightaway during reduction of the 5-nitro group to the corresponding 5-amino group leading to the intermediary 7,8-dihydro-7-methyl-(15), 7,8-dihydro-7-isopropyl-(16) and 7,8-dihydro-7-phenyl-l,3-dimethyl-5//-lumazin-6-one (17) which can be oxidized by permanganate to the corresponding 7-substituted 1,3-dimethyl-5//-lumazin-6-ones 18-20.
We treated the 6-substituted 7-hydroxy-1,3-dimethyllumazines 5-7 in analogy the former investigation (8) with H 2 0 2 in trifluoroacetic acid and obtained the corresponding 5-N-oxides 21 and 22 whereas 6 could not be oxidized from steric reasons due to the bulky adjacent 6-tcrt.butyl group. Analogous oxidations in the 6-oxo-lumazine series were less successful since only 20 afforded a reaction at the N-5 atom leading to 23 which we consider as a cyclic hydroxamic acid. 
Structural Assignments and Physical Data
The newly synthesized compounds have been characterized by their elemental analysis, their Ή-NMR (experimental part) and UV spectra (table 1 ). Since the Ή-NMR spectra are relatively simple and not much conclusive more structural information can be obtained from the UV spectra of which the neutral form and monoanion based upon their pKa values have been determined. Tab. 1.
The 7-hydroxy-1,3-dimethyllumazines (5-7) are much stronger acids then the 6-hydroxy isomers (18-20) seen by pK a differences of 2-3 and is due to the fact that anion stabilization by resonance is more distinct in the former series. The characteristic long wavelength absorption bands do not differ much going from the neutral species to the monoanion form but show in general an increase in the extinction coefficient. The phenyl substituent in 6-and 7-position causes a bathochromic shift indicating an electronic interaction with the lumazine nucleus. Oxidation to the 7-hydroxy-1,3-dimethyllumazinc-N-oxides (21, 22) increases expectedly the acidity of the basic molecules by 0.5 pK. a units due to a more severe eicctron-attraction of the N-oxide function. The proof of structure of 5.6-Dihydro-5-N-hydroxy-l,3-dimethyl-6-oxolumazine (23) resulting from oxidation of 20 is based on the facts that N-oxidation in the lumazine series (8, 10) has so far never taken place at the adjacent ring-nitrogen atom of a phenyl group as well as at the peri-position to an N-l substituent. From these reasons the N-8 atom in 20 is very strongly sterically hin- dcrcd and react therefore at N-5 to the corresponding hydroxamic acid 23. The acidity of 23 is increased and the strong bathochromic shift in the monoanion to 447 nm is in good agreement with the propsed structure.
Experimental Part
General TLC: precoated cellulose thin-layer sheets F 1440b LS 254 and silica gel thin-layer sheets F 1500 LS 254 from Schleicher and Schiill. Preparative TLC: silica gel 60 PF 254 from Merck. M.p.: Buchi apparatus, model Dr. Tottuli; no corrections. The pK a measurements were performed by the spectrophotometric method (9) . UV: Cary Recording spectrometer, model 15; X max (nm); log ε; [ ] shoulder. 'H-NMR: Bruker WM-250 spectrometer in δ (ppm) relative to TMS.
7-Hvdroxv-6-isopropvl-/,3-dimethvllumazine (6).
A solution of 1,3-dimethyluracil-5,6-diamine monohydrochloridc (1) (10) (6.0 g, 0.03 mol) in H 2 0 (300 ml) was neutralized by ammonia to pH 7 and then ethyl 2-oxo-3-methylburyrate (2) ( 1 1 ) added and heated under reflux for 30 min. The resulting colorless needles were collectcd (5.2 g) after cooling to room temperature, the filtrate concentrated to 100 ml and the second crop (2.6 g) filtered off. Recrystallization from MeOH/FFO 1:1 (225 ml) gave 6. (7) . A solution of l,3-dimethyluracil-5,6-diamine monohydrochloride (1) (10) (2.5 g, 0.014 mol) in FFO (60 ml) was neutralized by ammonia, then ethyl 2-oxo-3,3-dimethylbutyrate (12) added and the mixture refluxed for 30 min. The precipitate was collected after cooling overnight and gave after recrystallization from Me0H/H 2 0 1:1 (120 ml) 2.49 g (65%) of colorless 
7-Hydroxy-1,3-dimethyl-6-phenyllumazine (8).
Analogous to the preceding procedure with ethyl phenylpyruvate (4) (13) 
2-(I .3-Dimethyl-5-nìtrouracìl-6-ylamino)-propioiiic acid ethyl ester (12).
A suspension of alanine ethyl ester hydrochloride in CHCI3 (40 ml) was stirred in an icebath with 2% aqueous ammonia (400 ml) for 30 min, the CHC1, layer separated, dried over Na2S04 and evaporated. The resulting oil was dissolved in CHC13 (60 ml) again and then a solution of 6-chloro-l,3-dimethyl-5-nitrouracil (8) (14) (28 g, 0.12 mol) in CHCI3 (60 ml) dropwise added with stirring for 20 min. The reaction solution was treated twice with H20 (300 ml), the CHCI3 layer dried over Na2S04. It was evaporated, coevaporated with n-butanol and the resulting crystal cake recrystallized from n-BuOH (100 ml) with charcoal to give 18. 
2-( 1.3-Dìmethy1-5-nitrouracH-6-y lamino )-3-methylbutyric acid ethyl ester (13).
To a stirred solution of 8 (21.9 g, 0.1 mol) in CHCI3 (400 ml) was dropwise added a solution of valine ethyl ester (10) (29 g, 0.2 mol) in CHC13 (150 ml) and stirring continued for 30 min. The reaction solution was treated 3 times with H20 (500 ml), the CHC13 layer dried over Na2S04, evaporated and the resulting oil treated with ether (50 ml). After scratching with a glasrod and slow evaporation on air gave a crystalline material which was dried in a vacuum desiccator. 
2-( 1,3-Dimethyì-5-nitrouracil-6-ylamiììo)-2-phenyì acetic acid ethyl ester (14).
A solution of phcnylglycin ethyl ester (8. 
5,6, 7,8-Tetrahvdro-7-isopropyl-1,3-dimethyl-6-oxolumazine (16).
Analogous to the preceding procedure with 13 (11.8 g, 0.036 mol) and Raney-Ni ( 1.3 g) in EtOH (400 ml). After 2 days 2.8 1 of H2 were consumed, the solution heated and then the catalyst filtered off. The filtrate was evaporated, the residue recrystallized from H20 with charcoal to give 5. To a warm solution of 15 ( 0.9 g, 4 mmol) in H20 (100 ml) was added H202 (30%, 5 ml) and then air bubbled through the solution for 6 h. It was evaporated and the residue recrystallized from H:0 with charcoal to give 0.44 g (50%) of yellow needles of m.p. 282°C. Lit. (6) 
5,6-Dihydro-7-ixopropyf-1,3-dimethyl-5-oxohtmazine (19).
A hot solution of 16(1.5 g, 4.6 mmol) in H20 (250 ml) were treated with KMn04 (0.9g) in H20 (100 ml) by dropwise addition. After cooling the Mn02 was filtered off, extracted with hot MeOH (3 χ 100 ml) and then the united filtrates evaporated to dryness. A suspension of 14 (3.0 g, 8.3 mmol ) in MeOH ( 1 50 ml) was reduced with Raney-Ni ( 1 g) under H2-atmosphere in a shaking apparatus. After 1 2 h the theoretical amount of Il2 (620 ml) was consumed. The catalyst was filtered off, washed with hot MeOH (2 χ 50 ml) and then the united filtrates evaporated to dryness to give 17 as a crude material. During recrystallization from hot F.tOH oxydation took place and on cooling 1.2 g (51%) of yellow crystals of m.p. 327-328°C (LU. (10) 327°C ) Hydmxy-6-isopropyl-1,3-dimelhyllumazine-5-N- 
7-

oxide (21).
A solution of 5 ( 1.5 g, 6 mmol) in CF.COOH (7 ml) was cooled to 0-5°C with ice and then H202 (85%, 1.5 ml) added slowly dropwise with stirring. After 1 h was diluted with H20 (20 ml) and then carefully evaporated in vaccum.The residue was coevaporated with H20 (5 χ 20 ml), the resulting residue treated with H20 (40 ml), the pH adjusted to 9 with cone. NH3, the insoluble material filtered off and the filtrate acidified with conc. HCl to pH 0 to give 0. 
7-Hvdroxv-6-phenvlIumazine-5-N-oxide (22).
Analogous to the preceding procedure with 7 ( 1.0 g, 3.5 mmol) in CF.COO 11 (6 ml) and H202 (85%, 1 ml). To a cold solution of 20 (0.8 g, 2.8 mmol) in CF ;COOH (4 ml) was added H202 (85%, 0.8 ml) slowly dropwise with stirring. After 2 h at 10°C was carefully evaporated at a bath temperature of 40°C in vacuum, the residue coevaporated with H20 (5 χ 20 ml) and then the residue heated in H20 (100 ml) to boiling. On cooling the solid was collected and dried to give 0.56 g (66%) of orange-colored crystals of m. 
